Work

Thromboprophylaxis in multiple myeloma: is the evidence there?

Year: 2012

Type: article

Abstract: The clinical outcome of patients diagnosed with multiple myeloma has improved with the introduction of the immunomodulatory drugs (IMiDs) thalidomide and lenalidomide [1–3]. Simultaneously, a high ...

Source: Expert Review of Anticancer Therapy

DOI: 10.1586/era.11.214

Authors: Sigurdur Yngvi Kristinsson, Ola Landgren

Institutions: Karolinska University Hospital, Karolinska Institutet, National Institutes of Health, National Cancer Institute

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institutes of Health, National Cancer Institute

Awards: Molecular and clinical profiling, Population based studies

OpenAlex ID: W2008310639

FWCI: 0.213

Cites: 24

Cited by: 7

Related to: 10